Global Precision Medicine Market Is Expected To Reach Around USD 86.25 Billion By 2025

Zion Market Research has published a new report titled “Precision Medicine Market By Technology (Bioinformatics, Genomic Sequencing, Drug Discovery, Companion Diagnostics, Big Data Analytics Software, and Others), By Application (Oncology, Immunology, Respiratory, CNS, and Others), and By End-User (Pharmaceutical Companies, Biotechnology Companies, Diagnostic Laboratories, Healthcare-IT/Big Data Firms, Clinical Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global precision medicine market was USD 43.98 billion in 2018 and is anticipated to reach around USD 86.25 billion by 2025, growing at a CAGR of around 10.1% between 2019 and 2025.

Precision medication (PM) is a form of medication that uses data about a person’s genes, proteins, lifestyle, and environment to forestall, diagnose, and treat diseases. This approach enables researchers and doctors to predict more accurately the treatment and prevention methods for a selected disease that can work for particular individuals.

Browse the full “Precision Medicine Market By Technology (Bioinformatics, Genomic Sequencing, Drug Discovery, Companion Diagnostics, Big Data Analytics Software, and Others), By Application (Oncology, Immunology, Respiratory, CNS, and Others), and By End-User (Pharmaceutical Companies, Biotechnology Companies, Diagnostic Laboratories, Healthcare-IT/Big Data Firms, Clinical Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/precision-medicine-market

The increasing acceptance rate of gene therapies in developed economies with a comparatively high-revenue can enhance the precision medicine market growth in the years ahead. Ascending incidences of genetic disorders and cost-efficiency of sequencing has is also contributing to the precision medicine market commercially. Moreover, growing analysis and development activities that reinforce the assembly and producing of precision medication is further driving this market globally. However, deviation from treatment-based to preventive healthcare, abstaining trends in food and drug administration pharmacotherapy approval rate, the encroachment of privacy rules, and misconception of genetic and health data may limit the precision medicine market growth.

By technology, the market is divided into drug discovery, big data analytics, bioinformatics, companion diagnostics, genomic sequencing, and others. The drug discovery segment holds the largest market share, of about 25%. Human genome information obtained for immunologic processes is complicated. Big data analytics helps in segregating the obtained information and alter it to develop immunologic therapies. These software systems permit the convenience of vaccines and precision medicines altered in line with a person’s genome.

Based on application, the market includes respiratory, oncology, CNS, immunology, and others. Oncology is likely to witness the highest CAGR in the market over the forecast timeframe. Immunology accounted for the second-largest market share in 2018 and is anticipated to indicate similar growth trends over the forthcoming years. Utilization of information obtained from advanced platforms like large data analytics and bioinformatics large can accelerate the treatment process.

By end-user, the market includes pharmacy and biotechnology firms, diagnostic companies, healthcare-IT/big data firms, clinical laboratories, and others. Healthcare-IT/big data firms are predicted to hold a substantial share in the precision medicine market over the estimated timeframe. This can be attributed to the growing convenience of precision medicine software systems and rising stress on providing customized drugs in hospitals. Diagnostic laboratories contributed the second-largest revenue share in 2018, due to the growing technology enactment rate by diagnostic laboratories that guarantees top-quality medical diagnostic devices by utilizing the software package for information repository.

North America is likely to account for the most important share of the precision medicine market over the forecast timeframe, owing to the increasing geriatric population suffering from chronic diseases like cancer, cardiovascular diseases, diabetes, etc. The Asia Pacific precision medicine market is projected to grow notably in the future, owing to the rising burden of genetic diseases in China that will drive the demand for gene therapies.

Some major players of the precision medicine market are Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.

This report segments the global precision medicine market into:

Precision Medicine Market: By Technology

• Bioinformatics
• Genomic Sequencing
• Drug Discovery
• Companion Diagnostics
• Big Data Analytics Software
• Others

Precision Medicine Market: By Application

• Oncology
• Immunology
• Respiratory
• CNS
• Others

Precision Medicine Market: By End-User

• Pharmaceuticals Companies
• Biotechnology Companies
• Diagnostic Laboratories
• Healthcare-IT/Big Data firms
• Clinical Laboratories
• Others

Precision Medicine Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com